A pragmatic 12-week, randomized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-severe depressive episode
Year: 2011
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Authors: James Michael Martinez, Wayne Katon, John H. Greist, Kurt Kroenke, Michael E. Thase, Adam L. Meyers, Sara Elizabeth Edwards, Lauren B. Marangell, Scarlett Shoemaker, Ralph Swindle
Institutions: Eli Lilly (United States), University of Washington, Healthcare Technology Systems, Regenstrief Institute, Health Services Research & Development, Indiana University School of Medicine, Indiana University, Philadelphia VA Medical Center, University of Pittsburgh Medical Center, University of Pennsylvania
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Eli Lilly and Company
OpenAlex ID: W2019015777